Showing 681 - 700 results of 224,815 for search '(( 50 ((we decrease) OR (greater decrease)) ) OR ( 10 ((nn decrease) OR (a decrease)) ))', query time: 1.44s Refine Results
  1. 681
  2. 682
  3. 683
  4. 684

    The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

    Published 2025
    “…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  5. 685
  6. 686
  7. 687

    Forced WNT10A expression and WNT10A siRNA knockdown in kidney cell lines. by Ren-Jun Hsu (127121)

    Published 2012
    “…Conversely, RCC-1 and Caki-1 transfected with WNT10A siRNA showed significant decrease in cell proliferation as compared to cells transfected with reagent and scrambled siRNA controls. …”
  8. 688

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC<sub>50</sub> value in micromolar range. …”
  9. 689

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC<sub>50</sub> value in micromolar range. …”
  10. 690
  11. 691
  12. 692

    Resveratrol decreases proliferation of Cisplatin-sensitive A2780 cells but not Cisplatin-resistant A2780CP cells. by Sébastien Baribeau (512869)

    Published 2014
    “…<p>MTT assay was performed to evaluate A2780 and A2780 cell lines proliferation in response to 10 µM Cisplatin and increasing doses up to 60 µM of Resveratrol. …”
  13. 693

    Loss of <i>flp-1</i> decreases the nose touch response. by Ingrid Buntschuh (4729536)

    Published 2018
    “…<p>All <i>flp-1</i> and <i>daf-10</i> mutant alleles showed a decreased nose touch response. …”
  14. 694
  15. 695
  16. 696
  17. 697
  18. 698
  19. 699
  20. 700